You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

histone acetylation

Showing 1 - 25 of 320
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Assessing Causality of CREBBP and EP300 Variants.

Recruiting
  • Rubinstein-Taybi Syndrome
  • skin biopsy for the primary fibroblast culture and a 15 ml blood sample (3 unnamed samples of 5ml) in each of the 4 SRT patients included.
  • +4 more
  • Talence, France
    Centre Hospitalier Universitaire de Bordeaux
Oct 7, 2021

Metastatic Colorectal Cancer Trial in Australia (Sodium Valproate, Panitumumab, Cetuximab)

Recruiting
  • Metastatic Colorectal Cancer
  • Sodium Valproate
  • +2 more
  • Saint Leonards, New South Wales, Australia
  • +8 more
Jan 22, 2023

Bladder Cancer Trial in Chapel Hill, Philadelphia (Pembrolizumab, Entinostat)

Recruiting
  • Bladder Cancer
  • Chapel Hill, North Carolina
  • +1 more
Oct 10, 2022

Alzheimer, Dementia Trial in Bergen (Placebo, Nicotinamide Riboside supplementation 1000mg daily in total, Nicotinamide Riboside

Recruiting
  • Alzheimer Disease
  • Dementia
  • Placebo
  • +2 more
  • Bergen, Vestland, Norway
  • +1 more
Nov 25, 2022

Non Small Cell Lung Cancer, Solid Tumors, Adult, Endometrial Cancer Trial in Fairfax (TNG260, Pembrolizumab)

Recruiting
  • Non Small Cell Lung Cancer
  • +6 more
  • Fairfax, Virginia
    NEXT Oncology
Jun 7, 2023

Parkinson Disease Trial in Bergen (Nicotinamide Riboside, Placebo)

Recruiting
  • Parkinson Disease
  • Nicotinamide Riboside
  • Placebo
  • Bergen, Vestland, Norway
    Haukeland University Hospital
Nov 28, 2022

Ketosis, Type 2 Diabetes Trial in Kelowna (Ketone monoester, Placebo)

Completed
  • Ketosis
  • Type 2 Diabetes
  • Ketone monoester
  • Placebo
  • Kelowna, British Columbia, Canada
    University of British Columbia, Okanagan
Jul 29, 2022

Recurrent DLBCL Germinal Center B-Cell Type, Recurrent Lymphoma, Recurrent Transformed Non-Hodgkin Lymphoma Trial (Belinostat,

Not yet recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
  • +5 more
  • (no location specified)
Dec 2, 2022

Melanoma, Renal Cell Carcinoma, NSCLC Trial in United States (HBI-8000 in combination with nivolumab)

Active, not recruiting
  • Melanoma
  • +2 more
  • HBI-8000 in combination with nivolumab
  • Phoenix, Arizona
  • +5 more
Jun 11, 2022

Post-translational Modifications to Circulating Histones Via

Active, not recruiting
  • Pregnancy Related
  • Pre-Eclampsia
  • Analysis of post-translational histone modifications via mass spectrometry
  • Nîmes, Gard, France
    Nîmes University Hospital
Dec 1, 2021

Sarcoma Trial in Guangzhou (chidamide and toripalimab)

Recruiting
  • Sarcoma
  • chidamide and toripalimab
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Univerisity
Sep 4, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8 Trial in San Francisco (Pembrolizumab,

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Prognostic Stage IV Breast Cancer AJCC v8
  • Pembrolizumab
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jan 5, 2023

Skin Cells That Stop Replicating During Wound Healing

Completed
  • Healthy Volunteers
    • Baltimore, Maryland
      National Institute on Aging, Clinical Research Unit
    Feb 2, 2023

    Breast Cancer Trial in United States (carboplatin, paclitaxel albumin-stabilized nanoparticle formulation, vorinostat)

    Active, not recruiting
    Has Results
    • Breast Cancer
    • Birmingham, Alabama
    • +4 more
    Feb 1, 2023

    Metastatic Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7 Trial in New York, Nashville (Laboratory Biomarker Analysis,

    Active, not recruiting
    • Metastatic Uveal Melanoma
    • Stage IV Uveal Melanoma AJCC v7
    • New York, New York
    • +2 more
    Jun 29, 2022

    Multiple Myeloma Trial in Worldwide (ACY-241, Pomalidomide, Dexamethasone)

    Active, not recruiting
    • Multiple Myeloma
    • Tucson, Arizona
    • +24 more
    Dec 15, 2022

    HIV-1-infection Trial in Rotterdam (Valproic Acid, Pyrimethamine)

    Completed
    • HIV-1-infection
    • Rotterdam, Netherlands
      Erasmus MC
    Apr 28, 2021

    Twins Born in Guangzhou

    Recruiting
    • Twin Diseases
    • +4 more
    • No intervention
    • Guangzhou, Guangdong, China
      Guangzhou Women and Children's Medical Center
    Mar 21, 2022

    IVF Offspring Born in Guangzhou

    Recruiting
    • ART
    • +4 more
      • Guangzhou, Guangdong, China
        Guangzhou Women and Children's Medical Center
      Mar 21, 2022

      Neuroblastoma in Children Trial in Guangzhou (Tucidinostat and etoposide)

      Recruiting
      • Neuroblastoma in Children
      • Tucidinostat and etoposide
      • Guangzhou, China
        Sun Yat-sen University
      Jun 9, 2022

      Renal Cell Carcinoma Trial in United States (LBH589)

      Completed
      Has Results
      • Renal Cell Carcinoma
      • Fort Myers, Florida
      • +9 more
      Oct 26, 2021

      HIV-1-infection, Subtype b Trial (Decitabine cycle 1, Romidepsin cycle 1, Decitabine cycle 2)

      Recruiting
      • HIV-1-infection, Subtype b
      • Decitabine cycle 1
      • +7 more
      • Bruxelles, Belgium
      • +2 more
      Jan 30, 2023

      Brain Stem Tumor, Pineal Region Tumor, Recurrent Lymphoma Trial in United States (Entinostat, Laboratory Biomarker Analysis,

      Completed
      Has Results
      • Brain Stem Neoplasm
      • +9 more
      • Birmingham, Alabama
      • +20 more
      Jan 6, 2023

      Hyperglycemia, Postprandial, Overweight and Obesity, Diabetes Risk Trial in Kelowna (Exogenous ketone monoester)

      Completed
      • Hyperglycemia, Postprandial
      • +2 more
      • Exogenous ketone monoester
      • Kelowna, British Columbia, Canada
        University of British Columbia, Okanagan.
      Apr 26, 2021

      Offspring Born to Mothers With Polycystic Ovary Syndrome in

      Recruiting
      • PCOS
      • +6 more
        • Guangzhou, Guangdong, China
          Guangzhou Women and Children's Medical Center, China
        Mar 21, 2022